摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-氟苯甲酰基)托烷 | 96920-56-8

中文名称
3-(4-氟苯甲酰基)托烷
中文别名
——
英文名称
2-(4-Fluorobenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane
英文别名
(4-fluorophenyl)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)methanone
3-(4-氟苯甲酰基)托烷化学式
CAS
96920-56-8
化学式
C15H18FNO
mdl
——
分子量
247.31
InChiKey
SFKXMCNVYWUQCL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.5±32.0 °C(Predicted)
  • 密度:
    1.149±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090

文献信息

  • Medical fluid, a method of treatment and use of the fluid
    申请人:XVIVO PERFUSION AB
    公开号:US10271540B2
    公开(公告)日:2019-04-30
    A medical fluid for a harvested organ, tissue or part thereof, for evaluation and/or preservation. The fluid includes cocaine or a stimulating analog thereof; noradrenaline; and/or adrenaline. In addition, the fluid includes an oncotic agent, such as dextran; hormones, such as thyroxin; triiodotyronine; cortisone, insulin; and electrolytes and optionally nutrients in substantially physiological concentrations in a physiologically acceptable medium. In addition, the medical fluid further includes albumin in a concentration not exceeding 5.0%, and an oxygen carrier, such as erythrocytes. Further components may be dopamine; hydrocortisone; methylprednisolone; and a vasopressor agent, such as desmopressin. The cocaine; adrenaline; and noradrenaline are present in concentrations of each about 0.010 μM to 0.100 μM, for example in a ratio of 1:1:1.
    一种用于评估和/或保存摘取的器官、组织或其部分的医用液。该液体包括可卡因或其刺激类似物、去甲肾上腺素和/或肾上腺素。此外,该药液还包括一种抗肿瘤剂,如右旋糖酐;激素,如甲状腺素;三碘酪氨酸;可的松、胰岛素;以及电解质和生理上可接受的介质中基本为生理浓度的营养物质。此外,医用流体还包括浓度不超过 5.0% 的白蛋白和氧载体,如红细胞。其他成分可以是多巴胺、氢化可的松、甲基强的松龙和血管加压剂,如去氨加压素。可卡因、肾上腺素和去甲肾上腺素的浓度各约为 0.010 μM 至 0.100 μM,例如比例为 1:1:1。
  • A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID
    申请人:Vivoline Medical AB
    公开号:EP2568805A1
    公开(公告)日:2013-03-20
  • MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID
    申请人:Steen Stig
    公开号:US20130065218A1
    公开(公告)日:2013-03-14
    A medical fluid for a harvested organ, tissue or parts thereof, for evaluation and/or preservation. The fluid includes cocaine or a stimulating analogue thereof; nor-adrenalin; and/or adrenaline. In addition, the fluid includes an oncotic agent, such as dextran; hormones, such as thyroxin; triiodotyronine; cortisone, insulin; and electrolytes and optionally nutrients in substantially physiological concentrations in a physiologically acceptable medium. In addition, the medical fluid further includes albumin in a concentration not exceeding 5.0%, and an oxygen carrier, such as erythrocytes. Further components may be dopamine; hydrocortisone; methylprednisolone; and a vasopressor agent, such as desmopressin. The cocaine; adrenalin; and noradrenaline are present in concentrations of each about 0.010 μM to 0.100 μM, for example in a ratio of 1:1:1.
  • COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING POTENTIAL ORGAN DONOR
    申请人:VIVOLINE MEDICAL AB
    公开号:US20160354359A1
    公开(公告)日:2016-12-08
    A composition, an infusion solution, a method for treatment, and a kit for intravascular administration for treatment of a brain-dead, heart-beating, respirated, potential organ donor. The composition has noradrenaline and a NET inhibitor for noradrenaline. The NET inhibitor may be cocaine or an analogue thereof or a tricyclic antidepressant. The composition may in addition include adrenaline, hydrocortisone, thyroxin, insulin, triiodotyronine, dopamine, a vasopressor agent, such as desmopressin, and methylprednisolone. The ratio between the NET inhibitor and noradrenaline is about 1:1. The composition may be dissolved in pure water, Ringer's acetate solution or physiological sodium chloride solution. The composition is infused in such an amount as to maintain a mean arterial pressure of about 60 mmHg. The composition may be infused by a pump at a rate of about 1.7 ml/hour decreasing dose-dependent to about 0.4 ml/hour after 24 hours.
  • US4366154A
    申请人:——
    公开号:US4366154A
    公开(公告)日:1982-12-28
查看更多